Can-Fite BioPharma (NYSE:CANF) Now Covered by StockNews.com
StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research note released on Thursday morning. The brokerage issued a hold rating on the stock. Separately, HC Wainwright reduced their target price on Can-Fite BioPharma from $34.00 to $18.00 and set a buy rating for the company in a research note […]
More Stories
Short Interest in Qube Holdings Limited (OTCMKTS:QUBHF) Expands By 17.6%
Qube Holdings Limited (OTCMKTS:QUBHF – Get Free Report) was the target of a significant increase in short interest in October....
Mycronic AB (publ) (OTCMKTS:MICLF) Short Interest Up 16.4% in October
Mycronic AB (publ) (OTCMKTS:MICLF – Get Free Report) was the recipient of a large increase in short interest during the...
Short Interest in Nemak, S. A. B. de C. V. (OTCMKTS:NMAKF) Rises By 21.6%
Nemak, S. A. B. de C. V. (OTCMKTS:NMAKF – Get Free Report) was the recipient of a significant increase in...
Short Interest in Green Thumb Industries Inc. (OTCMKTS:GTBIF) Drops By 21.3%
Green Thumb Industries Inc. (OTCMKTS:GTBIF – Get Free Report) was the target of a large decline in short interest in...
Genmab A/S (NASDAQ:GMAB) Short Interest Up 23.2% in October
Genmab A/S (NASDAQ:GMAB – Get Free Report) was the target of a significant increase in short interest during the month...
Short Interest in Invesco Dorsey Wright Basic Materials Momentum ETF (NASDAQ:PYZ) Decreases By 25.0%
Invesco Dorsey Wright Basic Materials Momentum ETF (NASDAQ:PYZ – Get Free Report) was the recipient of a significant decrease in...